
Venture capital · Early stage
BioGeneration Ventures
BioGeneration Ventures is the early-stage arm of the Forbion-BGV fund platform, based in Naarden, the Netherlands. It makes seed-stage investments in innovative European life sciences and biotech companies.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is BioGeneration Ventures right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register and SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds BioGeneration Ventures joined, from press and the firm’s own posts.
3 rounds in the last 12 months
Round sizes, BioGeneration Ventures’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company BioGeneration Ventures backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet BioGeneration Ventures
Events where BioGeneration Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
BioGeneration Ventures is based in Naarden, Netherlands.
10 fund vehicles are on public registers (ESMA register and SEC adviser filings), including BIOGENERATION CAPITAL FUND V, BIOGENERATION CAPITAL FUND III COOP and BIOGENERATION CAPITAL FUND IV COOP.
Stages: Seed, Early stage. Sectors: Biotech, Life sciences. From the firm’s own website.
Backs early-stage biotech companies that address high unmet medical needs with disruptive solutions, usually leading the seed round. Draws on industry experience and network in pharma and biotech to speed up product development and shape companies into attractive opportunities for industry. From the firm’s own website.
BioGeneration Ventures lists 42 portfolio companies on its website, including Artica Therapeutics, Avidicure, Azafaros, Brandaris Therapeutics and Brenig.
Firms whose websites list some of the same companies include Inkef, Seroba and Forbion.
Know before BioGeneration Ventures’s next round is announced.
PRO tracks BioGeneration Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.